Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple-negative breast cancer

1. Corrales-Sánchez, V.
2. Noblejas-López, M.D.M.
3. Nieto-Jiménez, C.
4. Pérez-Peña, J.
5. Montero, J.C.
6. Burgos, M.
7. Galán-Moya, E.M.
8. Pandiella, A.
9. Ocaña, A.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1111/JCMM.14980 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus